NT-101 Eye Drops for Age-Related Macular Degeneration

Recruiting in Palo Alto (17 mi)

+1 other location

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1 & 2

Recruiting

Sponsor: NexThera Co., Ltd.

No Placebo Group

Trial Summary

What is the purpose of this trial?

Phase 1/2 Trial NT-101 Topical Ophthalmic Solution in Patients with Wet Age-Related Macular Degeneration (AMD)

Eligibility Criteria

Inclusion Criteria

I am 50 years old or older.

I am using birth control as required.

Ability to instill eye drops in the study eye, willingness to comply with dosing regimen, and commitment to attending all study visits

Exclusion Criteria

Medical conditions that would preclude participation in the study

Pregnant, breastfeeding, or intending to become pregnant during the study

I had a YAG laser procedure on my eye within the last 2 months.

Participant Groups

Group I: NT-101 0.2 mM Experimental Treatment 1 Intervention

Group II: NT-101 0.05 mM Experimental Treatment 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Elman Retina Group Rosedale, MD

Erie Retina Research Erie, PA

Who Is Running the Clinical Trial?

NexThera Co., Ltd. Lead Sponsor

KCRN Research, LLC Industry Sponsor

References